Robertson Scott M. 4

4 · DICE Therapeutics, Inc. · Filed Sep 16, 2021

Insider Transaction Report

Form 4

Period: 2021-09-14

DICE Therapeutics, Inc.DICE

Robertson Scott M.

CFO & CBO

Transactions

Award
Stock Option (right to buy)
2021-09-14+7,191→ 7,191 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (7,191 underlying)
Award
Stock Option (right to buy)
2021-09-14+2,688→ 2,688 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (2,688 underlying)
Award
Stock Option (right to buy)
2021-09-14+16,595→ 16,595 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (16,595 underlying)
Award
Stock Option (right to buy)
2021-09-14+7,500→ 7,500 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (7,500 underlying)
Award
Stock Option (right to buy)
2021-09-14+5,000→ 5,000 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (5,000 underlying)
Award
Stock Option (right to buy)
2021-09-14+20,751→ 20,751 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (20,751 underlying)
Award
Stock Option (right to buy)
2021-09-14+15,000→ 15,000 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (15,000 underlying)
Award
Stock Option (right to buy)
2021-09-14+771→ 771 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (771 underlying)
Award
Stock Option (right to buy)
2021-09-14+9,095→ 9,095 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (9,095 underlying)
Award
Stock Option (right to buy)
2021-09-14+9,750→ 9,750 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (9,750 underlying)
Award
Stock Option (right to buy)
2021-09-14+920→ 920 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (920 underlying)
Award
Stock Option (right to buy)
2021-09-14+20,000→ 20,000 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (20,000 underlying)
Award
Stock Option (right to buy)
2021-09-14+2,500→ 2,500 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (2,500 underlying)
Award
Stock Option (right to buy)
2021-09-14+11,250→ 11,250 total
Exercise: $17.00Exp: 2031-09-14→ Common Stock (11,250 underlying)

Holdings

Common Stock
216,750

Footnotes (9)

[F1]The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
[F2]Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
[F3]The option is fully vested and exercisable.
[F4]The option vests as to 1/48th of the total shares monthly, beginning December 1, 2017, subject to the Reporting Holder's continuing employment with the Registrant.
[F5]The option vests as to 1/48th of the total shares monthly, beginning February 28, 2019, subject to the Reporting Holder's continuing employment with the Registrant.
[F6]The option vests as to 1/48th of the total shares monthly, beginning August 27, 2020, subject to the Reporting Holder's continuing employment with the Registrant.
[F7]The option vests as to 1/48th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continuing employment with the Registrant.
[F8]The option vests as to 1/48th of the total shares monthly, beginning August 2, 2021, subject to the Reporting Holder's continuing employment with the Registrant.
[F9]The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continuing employment with the Registrant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION